Medical biotech company Emergent BioSolutions is one of the many health industry players turning its efforts towards addressing the current global coronavirus pandemic. Their work includes a two-pronged effort to pursue plasma-based treatments that could help lessen the impact of COVID-19 on health care systems, with a fast-tracked development timeline that could see human clinical trials start as soon as this summer.
{iframe}https://techcrunch.com/2020/03/25/how-one-company-is-fast-tracking-development-of-potential-plasma-based-treatments-for-the-coronavirus/{/iframe}